Trial · NCT02167165
Role of SNP and DIGOXIN Response in Atrial Fibrillation Patients
NCT02167165, Completed, University of Monastir
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Role of SNP and DIGOXIN Response in Atrial Fibrillation Patients. Trials, record NCT02167165. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02167165
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Role of SNP and DIGOXIN Response in Atrial Fibrillation Patients
- NCT number
- NCT02167165
- Status
- Completed
- Enrollment
- 150 participants, actual
- Lead sponsor
- University of Monastir
- Conditions
- Atrial Fibrillation
- Interventions
- Digoxin Injection
- First posted
- 2014-06-18
- Last updated
- 2020-02-12
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Correlation between the response to digoxin and the genotypes of the patients | 24 hours | In the current study we aimed at outlining the different MDR-1, SLCO1B3, CYP11B12 and SCN5A genotypes in a sample of Tunisian patients, suffering from AF and taking digoxin, to assess the role of SNPs in affecting serum digoxin concentrations, and studying the consequences on patients' clinical outcome. Patients will be monitored for 24 hours in an intensive care unit; |
| Secondary | Rhythm and Rate control | 24 hours | Rhythm control: rate and delay of return to sinusal rhythm. Rate control: reduction of heart rate : HR \<100 bpm or 20% reduction from baseline |
| Other | Arterial hypotension Bradycardia (HR <45 bpm) Other (chest pain, allergic reaction……) | 24 hours | hypotension during hospitalisation, bradycardia, chest pain, allergic reaction |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02167165
GET https://conductscience.org/api/trials/v1/NCT02167165/registered